Telehealth GLP-1 prescriptions
A telehealth weight-care program that prescribes from a list of 14 medications, from compounded semaglutide and tirzepatide to Wegovy, Zepbound, Mounjaro, Ozempic and older oral drugs, with app-based coaching and an AI nutrition assistant.
We may earn a commission if you buy through the links to Found on this page, at no extra cost to you. That does not change how we grade or rank it, and Found did not write or approve this review.
quality claims we could confirm ourselves, rather than repeat from the vendor's marketing.
Compounded semaglutide and tirzepatide, brand-name GLP-1s, and oral options such as Contrave, metformin, topiramate and zonisamide.
Everything here is a prescription service that starts with a licensed clinician's review of your own health information. Compounded medications are made by a pharmacy against a prescription and are not FDA-approved or reviewed by the FDA for safety, effectiveness or quality. This entry describes what the brand offers and what we could check. It is not medical advice and not a recommendation to use it.
Every telehealth brand we rank gets the same five checks, read from its public pages on September 24, 2026. "Not met" means we did not find it, or the terms say otherwise, on the pages we could read. Price and commission play no part.
Shows both the 12-month prepay price and the month-to-month price ($289 cash, $199 insurance).
Its consent names the medical groups involved, including Pippen Health, Cloud Health Medical Group and OpenLoop Healthcare Partners.
Says it has relationships with third-party pharmacies but does not name them.
Full membership refund if cancelled within 3 days or before the first consultation. Medications are non-refundable once dispensed.
No warning letter under this name in FDA's public database on September 24, 2026.
Graded by whether we could confirm it ourselves or are only repeating what the vendor states. A vendor's honesty about its own testing is a different question from what a published trial shows, so this is a separate scale from the evidence grades on our guides.
Both prices are for 12-month plans paid up front, per the fine print on the pricing page. Month-to-month plans start at $289 cash and $199 with insurance. Most people comparing will see the lower number first. We confirmed this ourselves.
Where the vendor states thisThe page says this is from 1,773 users who reported their weight about weekly for a year, so it covers people who kept logging. It is company data, not a controlled study.
Where the vendor states thisWe counted the medication list on the page: compounded tirzepatide and semaglutide, Mounjaro, Zepbound, Wegovy, Ozempic, Saxenda, Victoza, Foundayo, Rybelsus, Contrave, metformin, zonisamide and topiramate. Which one you are offered is up to the prescriber.
Where the vendor states thisFDA does not review compounded drugs for safety, effectiveness or quality before they are sold. In 2026 FDA warned 30 telehealth companies over claims implying sameness with approved drugs, and proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, so the legal footing of this category can change.
$169 and $99 apply to 12-month plans paid up front. Monthly billing is $289 cash or $199 with insurance, which is the number to compare against other brands.
The page attributes the 20% figure to a 72-week Zepbound trial at the highest doses. Found's own reported average is 12% at one year.
The advertised $169 needs a 12-month prepay. Paid monthly, cash plans start at $289.
Every fact above traces to one of these pages, published by the vendor itself and checked on September 21, 2026. Vendor policy pages change without notice, so if something here looks out of date, it probably is.
Compare against
Open pricing, public COAs, strict research-only gate
